Saint Luke's Cancer Center - Allentown is a clinical research site located in Allentown, Pennsylvania, United States 18104.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Saint Luke's Cancer Center - Allentown has participated in 27 clinical trials with 25 currently active.
Therapeutic areas: Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.
Sponsors: National Cancer Institute (NCI), SWOG Cancer Research Network, NRG Oncology.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Saint Luke's Cancer Center - Allentown has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Saint Luke's Cancer Center - Allentown has 27 clinical trials on record, with 25 currently active. Their work covers Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.
Yes — Saint Luke's Cancer Center - Allentown holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.